Skip to content
Screener

EPS (Diluted) at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$9.84+213%
Mannkind logo
MannkindMNKD
-$0.06
United Therapeutics logo
United TherapeuticsUTHR
$7.27+13.4%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$1.06-783%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$0.10+63.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$0.84+4.5%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Total other expense, net(4,722)(2,942)
Income (loss) before income taxes56,782(38,367)
Income tax expense3,920
Net income (loss) and comprehensive income (loss)$52,862$(38,367)
Net income (loss) per common share, basic$0.60$(0.45)
Net income (loss) per common share, diluted$0.52$(0.45)
Weighted average common shares outstanding, basic88,006,24485,172,696
Weighted average common shares outstanding, diluted101,112,09585,172,696

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's EPS (diluted)?
Liquidia Corporation (LQDA) reported EPS (diluted) of $0.52 in Q1 2026.
How has Liquidia Corporation's EPS (diluted) changed year-over-year?
Liquidia Corporation's EPS (diluted) increased by 215.6% year-over-year, from -$0.45 to $0.52.
What is the long-term trend for Liquidia Corporation's EPS (diluted)?
Over 3 years (2021 to 2024), Liquidia Corporation's EPS (diluted) has grown at a 32.2% compound annual growth rate (CAGR), from -$0.71 to -$1.64.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Liquidia Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude